Squire Patton Boggs

19.03.2025 • Topics • Strategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

09.12.2019 • Topics • Strategy

China’s New Foreign Investment Law

09.05.2019 • Topics • Chemistry

Chemicals and a No-Deal Brexit

05.03.2018 • Topics • Strategy

Making Brexit Work for the Chemical Industry

27.07.2015 • Topics • Chemistry

Beyond REACh: Nanomaterials in the European Union

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Interview

Strategic Response to a Shifting Pharma Landscape

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Squire Patton Boggs